Rate My Professor Kim San

Dr. Tang has published extensively on these topics. Notable publications include "Neuroprotective properties of zinc oxide nanoparticles: therapeutic implications for Parkinson’s disease" (Bioscience Reports, 2024), "Paraquat and Parkinson’s Disease: the molecular crosstalk of upstream signal transduction pathways leading to apoptosis" (Current Neuropharmacology, 2024), "Investigating the Potential of Yttrium Oxide Nanoparticles and Zinc Oxide Nanoparticles for Parkinson’s Disease Treatment" (NeuroSci, 2025), "The current and future perspectives of zinc oxide nanoparticles in biomedicine" (Journal of Drug Targeting, 2019), "Protective Effects of Polydatin Against Dementia-Related Disorders" (Nutrients, 2022), and "Protective effect of arachidonic acid and linoleic acid on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mitochondrial dysfunction and cytotoxicity in PC12 cells" (Lipids in Health and Disease, 2014). He has received a scholarship from the International Society of Neurochemistry and the ‘Focus on Stroke’ Postdoctoral Fellowship Award from the Heart and Stroke Foundation of Canada. In 2018, he was awarded MUPA's Supervisor of the Year at Monash University Malaysia. Dr. Tang teaches units including PHR1031, PHR1022, PHR2042, BPS2011, and BPS3032 in the Bachelor of Pharmacy and Bachelor of Pharmaceutical Science programs, contributing to pharmacy education.